ERBB2 and breast cancer: Moreover, we further predicted the prognostic values of these genes associated with OS in BC patients with different stages, ages, molecular subtypes, ER/PR/HER2 status, TNM status, and TP53 mutation status, in addition to their expression levels using Cox Proportional‐Hazards model based on TCGA cohorts.